Catalyst Wire Dossier Catalyst Wire Dossier

0444 Gel

· Fougera Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 0444 Gel, covering 2014-07-04 to 2014-07-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea [Phase 3]

See pricing